← Back to all trials
Active Not Recruiting
NCT05654415
Melatonin vs Sleep Deprivation for Nap EEG
Conditions: Epilepsy
Sex: All
Ages: 4 Years – 10 Years
Phase: NA
Enrollment: 30
Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation
Location: Italy
Summary
In the pediatric population, electroencephalographic (EEG) recordings are frequently performed in sleep, as it reduces the amount of artifacts and might activate epileptiform discharges.
To date, no agreed-upon guidelines are available for hypno-induction for EEG recordings .
Among the strategies used, the most commonly used are sleep deprivation, either total or partial, and the use of melatonin, alone or in combination.
The investigators proposed a study aiming at evaluating the efficacy of a melatonin-based solution for sleep induction during EEG video recording VS sleep deprivation.In a randomized, crossover study, 30 pediatric patients (aged 4-10 years) will be subjected to two EEG recordings: in one they will receive the melatonin solution (5 mg), in the other they undergo only partial sleep deprivation (about 50% of physiological sleep).
The primary endpoint of the study is represented by the time to fall asleep, secondary objectives are represented by frequency of epileptiform discharges, presence/absence of epileptic seizures, In addition, the levels of 6-sulfatoxymelatonina, the primary metabolite of melatonin in saliva and urine, will be determined with a validated LC-MS method.
Eligibility Criteria
Inclusion Criteria:pediatric patients with epilepsy aged between 4 and 10 years with normal psychomotor development and IQ> 70;stable seizure frequency in the 3 months preceding the enrollment ;stable anti-seizure medications in the 3 months preceding the enrollment;written informed consent from the legal representative.Exclusion Criteria:subjects diagnosed with obstructive sleep apnea or other sleep disorders;history of neurodevelopmental disorders;concomitant use of hypnotics, stimulants, systemic corticosteroids or other immunosuppressants;concomitant daily use of melatonin;any conditions which, in the investigator's judgment, would compromise the achievement of the study objectives;refusal to sign the informed consent from the legal representative.
Source: ClinicalTrials.gov (NCT05654415). StuddyBuddy aggregates publicly available trial information.